MATTHEW CRONIN: Open Payments
NPI 1811505969 · WORCESTER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$190 in 8 payments from 7 companies in 2025. Trend: 2023 $170 · 2024 $22 · 2025 $190
Food & beverage: $147Education: $43
| Company | Payments | Amount |
|---|---|---|
| Mannkind Corporation | 1 | $43 |
| CeQur Corporation | 1 | $34 |
| Sequel Med Tech, LLC | 1 | $32 |
| Xeris Pharmaceuticals, Inc. | 1 | $25 |
| Insulet Corporation | 1 | $19 |
| Tandem Diabetes Care, Inc. | 1 | $19 |
| BETA BIONICS, INC. | 2 | $18 |
Products named: AFREZZA, CeQur Simplicity, TWIIST, GVOKE HYPOPEN, Omnipod, t:slim X2 Insulin Pump with Control-IQ, iLet Bionic Pancreas.
Industry payments across MA — which companies pay providers there.
